Prenatal exposure to benzodiazepines and Z-hypnotics was not associated with increased risk of ADHD in exposed children. The post Risk of ADHD in Kids with Prenatal Exposure to Benzodiazepines or Z-Hypnotics appeared first on MGH Center for Women's Mental Health ..read more

Every week we review the most recent publications in women’s mental health. The post Weekly Roundup for JANUARY 27, 2023: Recent Publications in Women’s Mental Health appeared first on MGH Center for Women's Mental Health ..read more

Every week we review the most recent publications in women’s mental health. The post Weekly Roundup for JANUARY 20, 2023: Recent Publications in Women’s Mental Health appeared first on MGH Center for Women's Mental Health ..read more

In this retrospective study of Taiwanese women using antipsychotic medications there was no observed increase in risk of metabolic complications. The post Antipsychotic Medication Use in Pregnancy and Risk of Maternal and Neonatal Metabolic Complications appeared first on MGH Center for Women's Mental Health ..read more

Women undergoing infertility treatment, as well as women who conceived after infertility, experienced significant levels of distress as a result of the COVID-10 pandemic. The post Understanding the Impact of the COVID-19 Pandemic on the Psychological Well-Being of Individuals Undergoing Infertility Treatment  appeared first on MGH Center for Women's Mental Health ..read more

Every week we review the most recent publications in women’s mental health. The post Weekly Roundup for JANUARY 13, 2023: Recent Publications in Women’s Mental Health appeared first on MGH Center for Women's Mental Health ..read more

Two studies - one using neuropsychological assessments, another examining performance on standardized testing - show no association between prenatal antipsychotic exposure and neurodevelopmental outcomes. The post Reassuring Data on Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antipsychotic Medications appeared first on MGH Center for Women's Mental Health ..read more

Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the long-term behavioral follow-up of children exposed to mood stabilizers and antidepressants with Ob.Gyn News on August 16, The post Long-term behavioral follow-up of children exposed to mood stabilizers and antidepressants: A look forward – ObGynNews appeared first on MGH Center for Women's Mental Health ..read more

Every week we review the most recent publications in women’s mental health. The post Weekly Roundup for JANUARY 6, 2023: Recent Publications in Women’s Mental Health appeared first on MGH Center for Women's Mental Health ..read more

A New Drug Application for zuranolone awaits FDA approval for the treatment of major depressive disorder (MDD) and postpartum depression (PPD). The post Zuranolone: Novel, Rapid-Acting Antidepressant Awaits FDA Approval appeared first on MGH Center for Women's Mental Health ..read more